This Week in PLOS

An updated version of a model that uses patient age and five blood protein biomarkers can differentiate between children with septic shock who are at high- or low-risk of mortality, according to a new analysis appearing in PLOS One. Researchers from the Cincinnati Children's Hospital and elsewhere tested their Pediatric Sepsis Biomarker Risk Model (PERSEVERE) on 182 one-year-old to 13-year-old children treated for septic shock at various intensive care units.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.